LDLR and atherosclerosis: Since TIGIT can directly inhibit T cell proliferation, we determined ex vivo the capacity of the agonistic anti-TIGIT antibody to impair T cell reactivity in our atherosclerosis mouse model; LDLr−/− mice fed a Western-type diet.